Good outcomes relative to bariatric surgery after catheter ablation in observational data ...

March 18, 2026 expert reaction to observational study on GLP-1 receptor agonists and lower risk of worsening mental illness, as published in The Lancet Psychiatry . experts commen ...

March 4, 2026 expert reaction to cohort study on GLP-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes . A cohort study published in T ...

Two peer-reviewed studies published in Obesity Pillars report that Ivim Health patients receiving GLP-1 therapy within a comprehensive care protocol achieved up to 26.54% average weight loss in ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...